www.benzinga.com Open in urlscan Pro
151.101.66.137  Public Scan

URL: https://www.benzinga.com/news/24/08/40155773/ascendiant-capital-initiates-coverage-on-mira-pharmaceuticals-with-buy-ratin...
Submission: On August 05 via api from BE — Scanned from DE

Form analysis 0 forms found in the DOM

Text Content

THE ONLY MONTHLY MEMBERSHIP WITH A POSITIVE ROI!





 * Get Benzinga Pro
 * Data & APIs
 * Events
 * Marketfy
 * Premarket
 * Boost
 * Advertise

Contribute
España
India
Italia
대한민국
日本
LoginRegister
 * Our Services
 * News
   Earnings
   Guidance
   Dividends
   M&A
   Buybacks
   Legal
   Interviews
   Management
   Offerings
   IPOs
   Insider Trades
   Biotech/FDA
   Politics
   Government
   Healthcare
 * Markets
   Pre-Market
   After Hours
   Movers
   ETFs
   Forex
   Cannabis
   Commodities
   Binary Options
   Bonds
   Futures
   CME Group
   Global Economics
   Mining
   Previews
   Small-Cap
   Real Estate
   Cryptocurrency
   Penny Stocks
   Digital Securities
   Volatility
 * Options
 * Ratings
   Analyst Color
   Downgrades
   Upgrades
   Initiations
   Price Target
 * Ideas
   Trade Ideas
   Long Ideas
   Short Ideas
   Technicals
   From The Press
   Jim Cramer
   Rumors
   Stock of the Day
   Best Stocks & ETFs
   Best Penny Stocks
   Best S&P 500 ETFs
   Best Swing Trade Stocks
   Best Blue Chip Stocks
   Best High-Volume Penny Stocks
   Best Small Cap ETFs
   Best Stocks to Day Trade
   Best REITs
 * Money
   Investing
   Cryptocurrency
   Mortgage
   Insurance
   Yield
   Personal Finance
   Forex
   Startup Investing
   Real Estate Investing
   Prop Trading
   Credit Cards
 * Crypto
 * Cannabis
   Cannabis Conference
   News
   Earnings
   Interviews
   Deals
   Regulations
   Psychedelics
 * Jobs


Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs

Research

My Stocks

Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
RecentMarkets

SPY

511.823.96%

QQQ

424.785.34%

SPIKE

23.51-

BTC/USD

51353.5811.7758%

DIA

386.532.67%

GLD

220.632.09%

TLT

99.691.43%



ASCENDIANT CAPITAL INITIATES COVERAGE ON MIRA...

by Benzinga News Desk



August 5, 2024 6:16 AM | 18 seconds read | Make a Comment



Never miss a trade again with the fastest news alerts in the world!

This headline only article is a sample of real-time intelligence Benzinga Pro
traders use to win in the markets everyday.

Want the fastest, most accurate stock market intelligence? Want EXCLUSIVE
stories originated by Benzinga reporters? Join 10,000+ serious traders in the
Benzinga Pro community!

 * The most trusted brand in stock market news
 * Fatest intelligence & alerts
 * Active trader chat rooms
 * Option trade alerts
 * Only comprehensive mobile notifications solution
 * Welcoming & white glove support

Active My Free Trial

Be the first to comment!

COMMENTS


Close menu
Loading...

EarningsAnalyst RatingsOptionsDividendsIPOs
date
▲▼
ticker
▲▼
name
▲▼
Price Target
▲▼
Upside/Downside
▲▼
Recommendation
▲▼
Firm
▲▼
08/05/2024
MIRA
Mira Pharmaceuticals
→ $11— → BuyAscendiant Capital


Click to see more Analyst Ratings updates


Posted In: NewsPrice TargetInitiationAnalyst Ratings

Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports
and breaking news that affects the stocks you care about.

Join Now: Free!
Already a member?Sign in


--------------------------------------------------------------------------------


SCILEX HOLDING COMPANY PROVIDES CERTAIN PRELIMINARY UNAUDITED FINANCIAL RESULTS
FOR THE MONTH ENDED JULY 31, 2024

by Scilex Holding Company


August 1, 2024 2:48 PM | 6 min read | Make a Comment

Partner Disclosure

PALO ALTO, CALIFORNIA – August 1, 2024 (GLOBE NEWSWIRE) – Scilex Holding Company
SCLX "Scilex" or the "Company"), an innovative revenue-generating company
focused on acquiring, developing and commercializing non-opioid pain management
products for the treatment of acute and chronic pain, today provided certain
preliminary unaudited financial results for the month ended July 31, 2024. 
Scilex generates continuous sales growth in ZTlido® going into third quarter of
2024 with preliminary net sales for ZTlido® in the range of $4.0 million to $5.0
million. The Company estimates that:  This preliminary financial data has been
prepared by and is the responsibility of Scilex. Scilex has not fully completed
its review of these preliminary financial results for the month ended July 31,
2024. Scilex's independent auditor has not reviewed or audited these preliminary
estimated financial results. Scilex's actual results may differ materially from
these preliminary financial results and may be outside the estimated ranges For
more information on Scilex Holding Company, refer to www.scilexholding.co For
more information on ZTlido® including Full Prescribing Information, refer to
www.ztlido.co
Read More



--------------------------------------------------------------------------------




BLOODBATH IN ASIA AND EUROPE, JAPAN'S INDEX CRASHES 13%; GOLD NEAR RECORD HIGHS
- GLOBAL MARKETS UPDATE WHILE US SLEPT

by Akanksha Bakshi, Benzinga Editor


August 5, 2024 6:44 AM | 3 min read | 1 Comment


ZINGER KEY POINTS

 * Japan’s Nikkei 225 closed drastically lower by 13.47% ending the session at
   31,078.00.
 * Crude Oil WTI traded lower by 1.97% at $72.09/bbl, and Brent was down 1.79%
   at $75.45 bbl.


On Friday, August 2, the U.S. stock markets closed lower, with the Nasdaq
Composite entering correction territory. A disappointing jobs report fueled
recession fears. Investors reacted negatively, signaling a shift in sentiment
where bad economic news is viewed as a genuine concern rather than a potential
trigger for Federal Reserve easing In economic data, the Labor Department
reported a gain of 114,000 jobs last month, falling short of the 175,000
forecast and the 200,000 needed to match population growth The unemployment rate
rose to 4.3%, near a three-year high, heightening concerns about a rapidly
slowing economy The Dow Jones Industrial Average was down 1.51% and closed at
39,737.26. The S&P 500 declined 1.84%, ending the day at 5,346.56, and the
Nasdaq Composite slid 2.43%, finishing the session at 16,776.16
Read More



--------------------------------------------------------------------------------




KEVIN O'LEARY ABOUT KAMALA HARRIS: 'IT'S NOT LIKE SHE JUST STARTED YESTERDAY.'
SAYS, 'WHEN YOU VOTE AND GET IT WRONG, I LOSE $50 MILLION'

by Adrian Volenik


August 4, 2024 11:58 AM | 4 min read | 1 Comment


Kevin O’Leary, most known as “Mr. Wonderful” from Shark Tank, recently sat down
with Chris Cuomo to share his thoughts on politics and investing in the current
climate. In the conversation, O’Leary deeply studied how the political
landscape, especially around Kamala Harris, influences his investment decisions.
Don't Miss For O’Leary, it’s not about whether you’re a Democrat or a
Republican. It's all about the policies that will impact businesses and
investments. “I’ve never made any money on politics. I’ve made money on policy,”
saying he spent the last three years rubbing shoulders with politicians from all
sides of the aisle, not just the red and blue During the interview, O’Leary
shared his thoughts on Vice President Kamala Harris and the challenges she faces
as a political leader. He was critical of Harris’s past performance and stressed
the importance of execution skills in the upcoming election. He said, “There
must be another woman of color that has better execution skills [than Harris] …
Certainly, there are other women.”  “She has a track record. It’s not like she
just started yesterday. She’s been here for over three and a half years. It
doesn’t matter what a Democrat says. It matters what the independent voter is
going to do in the seven states that matter.”
Read More



--------------------------------------------------------------------------------


Loading...
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on
the internet.
Click to Get Started



POPULAR CHANNELS

 * PreMarket Prep
 * Press Releases
 * Analyst Ratings
 * News
 * Options
 * ETFs


TOOLS & FEATURES

 * Real Time Feed
 * Public RSS Feeds
 * Submit News Tips
 * Blog
 * Embeddable Finance Widgets & Tools
 * Benzinga Catalyst


PARTNERS & CONTRIBUTORS

 * Affiliate Program
 * Contributor Portal
 * Licensing & Syndication
 * Sponsored Content
 * Advertise With Us
 * Lead Generation & SEO


ABOUT BENZINGA

 * About Us
 * Careers
 * In The News
 * Events
 * Contact Us

 * Terms & Conditions
 * Do Not Sell My Personal Data/Privacy Policy
 * Disclaimer
 * Service Status
 * Sitemap

© 2024 Benzinga | All Rights Reserved








Update Privacy Preferences